193 related articles for article (PubMed ID: 21713366)
1. Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC.
Quint K; Agaimy A; Di Fazio P; Montalbano R; Steindorf C; Jung R; Hellerbrand C; Hartmann A; Sitter H; Neureiter D; Ocker M
Virchows Arch; 2011 Aug; 459(2):129-39. PubMed ID: 21713366
[TBL] [Abstract][Full Text] [Related]
2. HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population.
Ler SY; Leung CH; Khin LW; Lu GD; Salto-Tellez M; Hartman M; Iau PT; Yap CT; Hooi SC
Oncol Rep; 2015 Nov; 34(5):2238-50. PubMed ID: 26352599
[TBL] [Abstract][Full Text] [Related]
3. Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis.
Shi W; Hu J; Zhu S; Shen X; Zhang X; Yang C; Gao H; Zhang H
Int J Clin Exp Pathol; 2015; 8(10):13083-9. PubMed ID: 26722504
[TBL] [Abstract][Full Text] [Related]
4. Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma.
Wu LM; Yang Z; Zhou L; Zhang F; Xie HY; Feng XW; Wu J; Zheng SS
PLoS One; 2010 Dec; 5(12):e14460. PubMed ID: 21206745
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.
Klieser E; Urbas R; Stättner S; Primavesi F; Jäger T; Dinnewitzer A; Mayr C; Kiesslich T; Holzmann K; Di Fazio P; Neureiter D; Swierczynski S
Hum Pathol; 2017 Jul; 65():41-52. PubMed ID: 28235630
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma.
Rikimaru T; Taketomi A; Yamashita Y; Shirabe K; Hamatsu T; Shimada M; Maehara Y
Oncology; 2007; 72(1-2):69-74. PubMed ID: 18004079
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.
Huang R; Zhang X; Sophia S; Min Z; Liu X
Anticancer Drugs; 2018 Apr; 29(4):364-370. PubMed ID: 29481474
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma.
Wang H; Kohashi K; Yoshizumi T; Okumura Y; Tanaka Y; Shimokawa M; Iwasaki T; Aishima S; Maehara Y; Oda Y
Hum Pathol; 2017 Jun; 64():69-75. PubMed ID: 28411180
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of histone deacetylase 2 predicts unfavorable prognosis in human gallbladder carcinoma.
Du X; Zhao H; Zang L; Song N; Yang T; Dong R; Yin J; Wang C; Lu J
Pathol Oncol Res; 2013 Jul; 19(3):397-403. PubMed ID: 23242568
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
11. Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas.
Campos B; Bermejo JL; Han L; Felsberg J; Ahmadi R; Grabe N; Reifenberger G; Unterberg A; Herold-Mende C
Cancer Sci; 2011 Feb; 102(2):387-92. PubMed ID: 21143702
[TBL] [Abstract][Full Text] [Related]
12. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.
Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L
Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587
[TBL] [Abstract][Full Text] [Related]
13. Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.
Weichert W; Röske A; Gekeler V; Beckers T; Ebert MP; Pross M; Dietel M; Denkert C; Röcken C
Lancet Oncol; 2008 Feb; 9(2):139-48. PubMed ID: 18207460
[TBL] [Abstract][Full Text] [Related]
14. The prognosis and clinicopathological significance of histone deacetylase in hepatocellular carcinoma: a meta-analysis.
Xue J; Ge P; Wu Y
Clin Exp Med; 2023 Sep; 23(5):1515-1536. PubMed ID: 36342581
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of HDAC9 in hepatocellular carcinoma.
Hu Y; Sun L; Tao S; Dai M; Wang Y; Li Y; Wu J
Cell Mol Biol (Noisy-le-grand); 2019 Apr; 65(4):23-28. PubMed ID: 31078148
[TBL] [Abstract][Full Text] [Related]
16. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
[TBL] [Abstract][Full Text] [Related]
17. Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective study.
Schmilovitz-Weiss H; Tobar A; Halpern M; Levy I; Shabtai E; Ben-Ari Z
Diagn Pathol; 2011 Dec; 6():121. PubMed ID: 22151825
[TBL] [Abstract][Full Text] [Related]
18. Expression of HDAC4 in Stage B Hepatocellular Carcinoma and Its Influence on Survival.
Wang Z; Wang H; Shen P; Xie R
Ann Clin Lab Sci; 2019 Mar; 49(2):189-192. PubMed ID: 31028063
[TBL] [Abstract][Full Text] [Related]
19. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
Ahn S; Hyeon J; Park CK
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
[TBL] [Abstract][Full Text] [Related]
20. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
Buurman R; Sandbothe M; Schlegelberger B; Skawran B
Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
